| Product Code: ETC9979077 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Viral Gastroenteritis Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Viral Gastroenteritis Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Viral Gastroenteritis Market - Industry Life Cycle |
3.4 United States (US) Viral Gastroenteritis Market - Porter's Five Forces |
3.5 United States (US) Viral Gastroenteritis Market Revenues & Volume Share, By Type Of Virus, 2021 & 2031F |
3.6 United States (US) Viral Gastroenteritis Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 United States (US) Viral Gastroenteritis Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 United States (US) Viral Gastroenteritis Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.9 United States (US) Viral Gastroenteritis Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United States (US) Viral Gastroenteritis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about viral gastroenteritis and its symptoms in the US |
4.2.2 Rising prevalence of viral gastroenteritis cases in the US |
4.2.3 Technological advancements in diagnostic tools and treatment options for viral gastroenteritis |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of viral gastroenteritis treatments |
4.3.2 High competition among market players leading to pricing pressures |
4.3.3 Limited reimbursement options for viral gastroenteritis treatments in the US healthcare system |
5 United States (US) Viral Gastroenteritis Market Trends |
6 United States (US) Viral Gastroenteritis Market, By Types |
6.1 United States (US) Viral Gastroenteritis Market, By Type Of Virus |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Viral Gastroenteritis Market Revenues & Volume, By Type Of Virus, 2021- 2031F |
6.1.3 United States (US) Viral Gastroenteritis Market Revenues & Volume, By Norovirus, 2021- 2031F |
6.1.4 United States (US) Viral Gastroenteritis Market Revenues & Volume, By Rotavirus, 2021- 2031F |
6.1.5 United States (US) Viral Gastroenteritis Market Revenues & Volume, By Astrovirus, 2021- 2031F |
6.1.6 United States (US) Viral Gastroenteritis Market Revenues & Volume, By Enteric Adenovirus, 2021- 2031F |
6.2 United States (US) Viral Gastroenteritis Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Viral Gastroenteritis Market Revenues & Volume, By Physical Examination, 2021- 2031F |
6.2.3 United States (US) Viral Gastroenteritis Market Revenues & Volume, By Rapid Stool Test, 2021- 2031F |
6.3 United States (US) Viral Gastroenteritis Market, By Drugs |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Viral Gastroenteritis Market Revenues & Volume, By Antibiotics, 2021- 2031F |
6.3.3 United States (US) Viral Gastroenteritis Market Revenues & Volume, By Antacids, 2021- 2031F |
6.3.4 United States (US) Viral Gastroenteritis Market Revenues & Volume, By Laxatives, 2021- 2031F |
6.3.5 United States (US) Viral Gastroenteritis Market Revenues & Volume, By Antimotility Agents, 2021- 2031F |
6.3.6 United States (US) Viral Gastroenteritis Market Revenues & Volume, By Others, 2021- 2031F |
6.3.7 United States (US) Viral Gastroenteritis Market Revenues & Volume, By Antiemetics, 2021- 2031F |
6.4 United States (US) Viral Gastroenteritis Market, By Indication |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Viral Gastroenteritis Market Revenues & Volume, By Watery Diarrhea, 2021- 2031F |
6.4.3 United States (US) Viral Gastroenteritis Market Revenues & Volume, By Vomiting, 2021- 2031F |
6.4.4 United States (US) Viral Gastroenteritis Market Revenues & Volume, By Abdominal Cramps and Pain, 2021- 2031F |
6.4.5 United States (US) Viral Gastroenteritis Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United States (US) Viral Gastroenteritis Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Viral Gastroenteritis Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 United States (US) Viral Gastroenteritis Market Revenues & Volume, By Clinics, 2021- 2031F |
6.5.4 United States (US) Viral Gastroenteritis Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F |
6.5.5 United States (US) Viral Gastroenteritis Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.5.6 United States (US) Viral Gastroenteritis Market Revenues & Volume, By Ambulatory Care Centers, 2021- 2031F |
6.5.7 United States (US) Viral Gastroenteritis Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Viral Gastroenteritis Market Import-Export Trade Statistics |
7.1 United States (US) Viral Gastroenteritis Market Export to Major Countries |
7.2 United States (US) Viral Gastroenteritis Market Imports from Major Countries |
8 United States (US) Viral Gastroenteritis Market Key Performance Indicators |
8.1 Number of reported cases of viral gastroenteritis in the US |
8.2 Adoption rate of advanced diagnostic tools for viral gastroenteritis |
8.3 Patient satisfaction scores with viral gastroenteritis treatment options |
8.4 Rate of new product development and innovation in viral gastroenteritis treatment |
8.5 Healthcare provider awareness and education programs on viral gastroenteritis |
9 United States (US) Viral Gastroenteritis Market - Opportunity Assessment |
9.1 United States (US) Viral Gastroenteritis Market Opportunity Assessment, By Type Of Virus, 2021 & 2031F |
9.2 United States (US) Viral Gastroenteritis Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 United States (US) Viral Gastroenteritis Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.4 United States (US) Viral Gastroenteritis Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.5 United States (US) Viral Gastroenteritis Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United States (US) Viral Gastroenteritis Market - Competitive Landscape |
10.1 United States (US) Viral Gastroenteritis Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Viral Gastroenteritis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here